CR6086 Uses, Dosage, Side Effects and more
CR6086 is under investigation in clinical trial NCT03163966 (A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in Dmard-naïve Patients With Early Rheumatoid Arthritis).
Trade Name | CR6086 |
Generic | CR6086 |
Type | |
Formula | C26H27F3N2O3 |
Weight | Average: 472.508 Monoisotopic: 472.197377226 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |